Clinical trial
Profiling Spike Protein Antibody Response Post COVID-19 Booster
NCT05476822 is registered in ClinicalTrials.gov with David Grant U.S. Air Force Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Profiling Spike Protein Antibody Response Post COVID-19 Booster
- Lead sponsor
- David Grant U.S. Air Force Medical Center
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- August 31, 2022
- Completion date
- June 30, 2023
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 booster, spike protein igg antibody